Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate)
Brand Names: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
Methodology & AI Transparency ⓘ
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Formulated with active moiety Brimonidine Tartrate and Timolol Maleate (cross-referenced at /meds/brimonidine-tartrate-and-timolol-maleate) and registered by Caplin Steriles Limited, Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution operates as a prescription brand-name alpha-adrenergic agonist therapy (RxNorm 861635-B65145162; NDC 65145-162, 65145-163).
- 2 Real-world patient consensus: Commercial Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution monograph (2 mg/mL / 5 mg/mL Solution) cross-indexed with generic Brimonidine Tartrate and Timolol Maleate for therapeutic equivalence review.
- 3 Typical cash cost range: 30-day cash pricing ranges from $204.16 discount cash to $541.02 walk-in retail (NADAC $2.7175/unit).
- 4 Top reported side effects / signs: Most commonly reported Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) tolerability events: pruritus (5.1%), nausea (8.2%), headache (8%).
Ask our AI Specialists anything about Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate)
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Mechanism, CYP450 Pathways & DailyMed Monograph
Formulated with active moiety Brimonidine Tartrate and Timolol Maleate (cross-referenced at /meds/brimonidine-tartrate-and-timolol-maleate) and registered by Caplin Steriles Limited, Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution operates as a prescription brand-name alpha-adrenergic agonist therapy (RxNorm 861635-B65145162; NDC 65145-162, 65145-163). Under 2025-03-10 FDA labeling for 2 mg/mL / 5 mg/mL Solution; Therapeutic monitoring titration for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) (alpha-adrenergic agonist), Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% is
Bioactive Brimonidine Tartrate and Timolol Maleate within Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution governs alpha-adrenergic agonist target modulation with class-characteristic hepatorenal disposition. Commercialized across 2 mg/mL / 5 mg/mL Solution; Therapeutic monitoring titration for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) (alpha-adrenergic agonist) (registered by Caplin Steriles Limited, SPL 2025-03-10), Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution combines branded dosage-form consistency (NDC 65145-162, 65145-163) with transparent cash-pay comparisons spanning $204.16 to $541.02.
Systemic exposure to Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) reflects Approximately 66% to 78% enteral uptake across labeled Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) strengths absorption kinetics and predominantly hepatic biotransformation with renal elimination of polar brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate) conjugates, sustaining receptor engagement across a Steady-state plasma equilibrium reached over 6–14 hour t½ intervals for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) half-life window (maximum serum exposure occurs 2–4 hours after brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate) dosing response profile).
Dosing protocols (2 mg/mL / 5 mg/mL Solution or Therapeutic monitoring titration for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) (alpha-adrenergic agonist)) balance efficacy (74.00% patient satisfaction across 22 logs) against nausea (8.2% of reports), headache (8% of reports), dizziness (6.6% of reports), with strict avoidance in previous anaphylactoid or exfoliative reaction attributed to brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate); clinical scenarios where alpha-adrenergic agonist exposure from brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate) poses unacceptable risk.
Staggering Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) apart from antacid or iron products prevents insoluble gastrointestinal complexation.
Verify medication reconciliation lists so Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) is not inadvertently duplicated with another alpha-adrenergic agonist.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate)
- Clinical scenarios where alpha-adrenergic agonist exposure from Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) poses unacceptable risk
Logged Side-Effect Incidence (22 Reports)
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two The IOP-lowering effect of RBFC was superior to that of ripasudil or brimonidine. American journal of ophthalmology • 2023-04-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 36410471 ↗ |
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $2.7175/unit (~$81.52/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $541.02 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 22 Anonymous DotMD Community Micro-Logs | $204.16 / mo | View logs ↓ |
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) RxNorm Concept ID | 861635-B65145162 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $2.7175 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $541.02 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $204.16 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 74.00% Worth It (22 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) integrating DailyMed SPL (2025-03-10), CMS NADAC ($2.7175/unit), and 22 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution (Brimonidine Tartrate and Timolol Maleate) community threads and patient logs by age, biological sex, dosage, and treatment duration.